Zimmer Biomet Holdings

At a glance

Zimmer Biomet Holdings reported 2025 revenue of $8.23B, up 7.2% from $7.68B in 2024. Over 4 years since 2021 ($6.83B), that is growth of about 4.8% a year. Operating margin was 13.3%, up from 12.6% in 2021. 2025 was the highest revenue year in this period.

In the last 12 months 4 insiders reported 0 open-market purchases and 5 sales ($1.6M). None of the sales were flagged as 10b5-1 plan trades. The largest was a sale of $529K by Grp Pres-Global Business Kevin R Thornal on Sep 15, 2026.

Zimmer Biomet Holdings filed 11 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), officer or director change (3), other events (1) and material agreement (1). The latest officer or director change was reported on Sep 8, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.

2 of the 20 investors tracked here held Zimmer Biomet Holdings at the last quarter end, worth $20.3M combined. It is the largest weight for Bridgewater Associates (0% of its portfolio), followed by National Pension Service (Korea) (0%). Added: Bridgewater Associates and National Pension Service (Korea).

Annual results

Fiscal year ends Dec 31 · incorporated in DE

Tracked investors holding (13F)

Weight is the share of each investor's portfolio, as of the quarter end.